GlassScriptPhysician profile
David N Socoloff
NPI 1295824175
$5,188.59
in general payments reported to CMS, 2019-2025
25 companies · $637 in 2025
The $637 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,013 · 2020: $370 · 2021: $797 · 2022: $1,250 · 2023: $959 · 2024: $162 · 2025: $637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,758.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,757.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,394.29 | 2019-2025 | Rinvoq, Skyrizi, Linzess |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $730.56 | 2019-2025 | Xifaxan, Trulance, Plenvu |
| Takeda Pharmaceuticals U.S.A., INC. | $525.39 | 2019-2025 | Entyvio, Gattex |
| Janssen Biotech, INC. | $457.54 | 2019-2025 | Tremfya, Stelara |
| Pfizer INC. | $323.96 | 2019-2024 | |
| Qol Medical, LLC | $250.61 | 2021-2023 | Sucraid |
| Celgene Corporation | $224.56 | 2021-2023 | Zeposia |
| Romark Laboratories, Lc | $193.43 | 2019-2020 | |
| Boston Scientific Corporation | $137.98 | 2020-2025 | Radial Jaw 4, Captivator II, Resolution 360 Clip |
| Daiichi Sankyo INC. | $135.00 | 2019-2023 | Injectafer |
| Braintree Laboratories, INC. | $127.70 | 2019-2023 | Sutab |
| Redhill Biopharma INC. | $102.74 | 2020-2022 | |
| Amgen INC. | $90.55 | 2021-2023 | Amjevita, Avsola |
| Nestle Healthcare Nutrition INC. | $84.06 | 2021 | |
| Vivus LLC | $63.33 | 2022-2023 | Qsymia |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $53.35 | 2022-2024 | Ibsrela |
| Ironwood Pharmaceuticals, INC | $52.56 | 2019-2022 | |
| Janssen Scientific Affairs, LLC | $45.56 | 2025 | Tremfya |
| Merck Sharp & Dohme LLC | $44.87 | 2021-2023 | Dificid |
| Allergan, INC. | $43.51 | 2019 | |
| Genzyme Corporation | $29.25 | 2023 | |
| Endo Pharmaceuticals INC. | $22.86 | 2019 | |
| Ferring Pharmaceuticals INC. | $20.60 | 2021 | |
| Phathom Pharmaceuticals, INC. | $18.57 | 2025 | Voquezna |
| Exact Sciences Corporation | $15.76 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Socoloff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.